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Abstract 
Ageing is characterized by immunosenescence and the progressive decline in immunity in 
association with an increased frequency of infections and chronic disease. This complex process 
affects both the innate and adaptive immune systems with a progressive decline in most immune 
cell populations and defects in activation resulting in loss of function. Although host genetics and 
environmental factors, such as stress, exercise and diet can impact on the onset or course of 
immunosenescence, the mechanisms involved are largely unknown. This review focusses on 
identifying the most significant aspects of immunosenescence and on the evidence that nutritional 
intervention might delay this process, and consequently improve the quality of life of the elderly. 
Keywords: Immunosenescence, ageing, nutrition 
1. Introduction 
Ageing is an irreversible process although improvements in public health, vaccination and 
healthier diets have contributed to an increase in average lifespans of the majority of citizens of 
developed countries. Ageing is associated with the functional decline of the immune system and 
ability to defend against infection by environmental pathogens, vaccine failure, and an increased 
incidence of autoimmunity and cancer (Castle, 2000; Dewan et al., 2012). 
Immunosenescence affects both innate and adaptive immunity (DelaRosa et al., 2006; Gomez et al., 
2008; Pawelec, 2006; Shaw et al., 2010; Solana et al., 2006), with alterations in constituent cells of 
both (Figure 1), linked to the onset of chronic disease. The design of interventional strategies to 
delay or possibly reverse immunosenescence requires a detailed understanding of how different 
immune cells become senescent. 
Although there is considerable heterogeneity among individuals owing largely to variations in 
genetics and polymorphisms of immune response genes such as MHC which cannot be altered, some 
factors such as lifestyle choices and nutrition (Pae et al, 2012) are amenable to modification and 
impacting the progression of immunosenescence. Of particular interest is the use of diet and 
*Manuscript
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nutritional supplementation to improve immune function in the elderly. This is rationalised on 
geographically distinct patterns of ageing and the decreased incidence of cardiovascular and other 
chronic diseases and increased longevity in populations such as those in regions of the 
Mediterranean that consume a diet rich in fruit, vegetables, legumes, unrefined cereals and olive oil, 
with low intake of meat and dairy products and moderate alcohol consumption, (Trichopoulou et al., 
2003; Vasto et al., 2012).  
The design of studies to evaluate the effects of nutrient supplementation is important and critical for 
determining efficacy and impact (Chandra, 2004). Different protocols exist for selecting participants 
for these studies. In 1984 the first specific criterion for participants in studies of immune ageing was 
described by the EU Concerted Action Programme on Ageing (EURAGE). Subsequently, the SENIEUR 
protocol was defined to better characterize “healthiness” (Ligthart et al., 1984) and excludes 
subjects who have chronic diseases, take medications or are in residential care. In recognising that 
undernutrition is common in elderly populations a nutritional criterion to measures the protein 
status of the subjects was added in 1988.  Finally, as micronutrient deficiencies may influence the 
immune response of elderly subjects, new criteria relating to micronutrient levels have been added 
(Lesourd and Mazari, 1999) and currently, elderly subjects who fulfil the SENIEUR criteria should 
have a serum albumin level of ≥ 39 g/l and no deficit in Zn, Se, Folic acid and vitamins C, E, B6 and 
B12. 
In this review we will summarise the impact ageing has on immune cells of both the innate 
(neutrophils, macrophages, NK cells) and adaptive (mainly T and B populations) immune system and 
the cells that bridge the two (DC) in addition to the effect that nutritional (micronutrients, 
macronutrients, functional foods, and whole diets) interventions have on these cells. 
2. Immunosenescence and inflammaging 
Advancing age is associated with an increased susceptibility of developing infections, frailty, 
cardiovascular disease, autoimmune disease (e.g. rheumatoid arthritis), metabolic syndrome, type II 
diabetes and cancer (Mitchell et al., 2010). This results in increases in healthcare costs, the need for 
residential care and a reduced quality of life. Immunosenescence describes age-related alterations in 
immune function, chronic inflammation and their link to increased risk of infection and age-
associated disease (Mitchell et al., 2010). Age-related changes to the immune system include 
dysfunctional B cells, T cells, monocytes, natural killer (NK) cells and neutrophils, thymic involution 
and a decline in T cell production, alterations in T-helper 1/ T-helper 2 (Th1/ Th2) profiles and the 
occurrence of an immune risk profile (IRP) characterized by an inverted CD4/CD8 ratio associated 
with persistent cytomegalovirus infection and an increases in the number of CD3+CD8+CD28- cells 
(Wikby et al., 2008). Increased susceptibility to infection is associated with decreased levels of 
interferon (IFN)-γ and increased levels of interleukin (IL)-4 and IL-10 (Rink et al., 1998). The reduction 
in IFN-γ is linked to decreased numbers of effector memory T cells and CD8+ cytotoxic T cells (Rink et 
al., 1998), which has been linked to lack of expression of the cell surface receptor CD28 and is a 
contributing factor to poor vaccine responses (Goronzy et al., 2001a; McElhaney et al., 2012). 
However, levels of other pro-inflammatory cytokines such tumor necrosis factor (TNF)-α and IL-6 
may be higher in healthy elderly subjects compared to young adults (Goronzy et al., 2012; 
Wordsworth and Dunn-Walters, 2011), contributing to inflammaging and recurrent and persistent 
infections in the elderly (Larbi et al., 2008a; McElhaney et al., 2012). The immune response in the 
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frail elderly however, differs to that of the healthy elderly (Jing et al., 2009). Of note, the proportion 
of elderly within the general population who fulfil strict inclusion criteria of the SENIEUR protocol is 
low; only 10-15% (Uyemura et al., 2002) meaning that the results from studies using the SENIEUR 
protocol for subject recruitment may not be representative of the majority of elderly people within 
the general population. 
The ageing organism is also characterized by a low grade chronic inflammation that results from 
alterations in the balance of production of pro-inflammatory versus anti-inflammatory mediators 
and cytokines and is termed ‘inflammaging’ (Wordsworth and Dunn-Walters, 2011). It would appear 
that inflammaging is under genetic control and is detrimental for longevity (Chung et al., 2002; 
Franceschi et al., 2000; Zanni et al., 2003). This age-related chronic inflammatory activity, leading to 
long term tissue damage, is related to increased mortality risk from all causes in old persons. 
Inflammaging is believed to be a consequence of a cumulative lifetime exposure to antigenic load 
caused by both clinical and subclinical infections as well as exposure to noninfective antigens (De 
Martinis et al., 2005). If true this would mean that, immunosenescence and probably morbidity and 
mortality will be accelerated in those subjects who are exposed to the highest burden of antigenic 
load. More recently, however it has been suggested that events taking place in the gastrointestinal 
tract may play an important role in triggering and/or nurturing the inflammaging process (Cevenini 
et al., 2013; Guigoz et al., 2008). Regardless of its origin, the consequent inflammatory response, 
tissue damage and production of reactive oxygen species that cause oxidative damage elicits the 
release of additional, amplifying cytokines, principally from cells of the innate immune system 
(Cannizzo et al., 2011). This results in a vicious cycle that, drives immune system remodelling and 
favour a chronic proinflammatory state where pathophysiological changes, tissue injury and healing 
proceed simultaneously. Irreversible cellular and molecular damage that is not clinically evident 
accumulates over decades.  
3. Ageing of the innate immune system 
3.1. Neutrophils in ageing 
Neutrophil numbers remain unchanged in the elderly (Chatta et al., 1993)) although their 
functionality is decreased (Gomez et al., 2008). Chemotaxis (Fortin et al., 2006; Fulop et al., 2004) 
and phagocytosis (Butcher et al., 2001; Wenisch et al., 2000) is decreased in healthy aged individuals 
and in advanced age there is delayed cellular apoptosis during inflammatory responses (Fortin et al., 
2007; Fulop et al., 1997; Tortorella et al., 2001; Tortorella et al., 2006). Studies of ROS production by 
neutrophils in the elderly have produced conflicting findings with some showing an increased 
production (De la Fuente, 2008; Ogawa et al., 2008) whereas others have reported decreased 
production of superoxide and hydrogen peroxide (Di Lorenzo et al., 1999; Fulop et al., 1985; Nagel et 
al., 1982). The use of different stimuli and bacterial strains in the different studies may explain these 
conflicting results. Age-related changes in intracellular signalling pathways have also been described 
including reduced phosphorylation of extracellular receptor-activated kinase (ERK) and mitogen-
activated protein (MAP) (Fulop et al., 2004; Larbi et al., 2005), signal tyrosine phosphatase-1 (SHT-1), 
and suppressor of cytokine signalling (SOCS) (Tortorella et al., 2006).  
3.2. Monocytes and macrophages in ageing 
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Monocyte/macrophage function changes with age although there are species differences 
(Gomez et al., 2008). While some studies in aged humans and mice have shown decreased 
macrophage chemotaxis and phagocytosis (De La Fuente, 1985; Fietta et al., 1993), similar studies in 
aged rats have reported opposite results (Corsini et al., 2005; Hilmer et al., 2007). In humans, 
although the total number of monocytes in the elderly are similar compared to that in younger 
individuals, there is a decrease in macrophage precursors in the bone marrow of the elderly (Ogawa 
et al., 2000). Antigen presentation is also decreased, probably due to reduced expression of MHC 
class II molecules (Herrero et al., 2002; Plowden et al., 2004; Zissel et al., 1999). Production of 
superoxide anion (Plackett et al., 2004), and phagocytic ability is reduced as are the levels of 
macrophage inhibitory protein (MIP)-1, MIP-1, MIP-2 and eotaxin production (Swift et al., 2001). 
Expression and function of certain Toll-like receptors (TLRs) and other pattern recognition receptors 
are also affected in monocytes (Alvarez-Rodriguez et al., 2012) as is the ability to express CD80/CD86 
co-stimulatory receptors after stimulation via TLRs (van Duin et al., 2007). 
3.3. NK cells in ageing 
The effect of ageing on the main DC56bright and CD56dim NK cell subsets and the expression and 
function of activating and inhibitory receptors has been extensively studied (Camous et al., 2012; 
Gayoso et al., 2011; Gomez et al., 2008). An increase in the absolute number of NK cells in the 
elderly (Borrego et al., 1999; Chidrawar et al., 2006; Le Garff-Tavernier et al., 2010), is associated 
with a decline in CD56bright NK cells and an increase in the CD56dim subset (Borrego et al., 1999; 
Chidrawar et al., 2006). Cytotoxicity, cytokine and chemokine production, proliferation and receptor 
expression are also adversely affected with age (Camous et al., 2012). CD56bright NK cells in the aged 
produce less chemokines in response to the activating cytokines IL-2 and IL-12 (Mariani et al., 2002a; 
Mariani et al., 2002b). In contrast, CD16 the low-affinity IgG receptor (FcRIII-A) involved in antibody 
dependent cell cytotoxicity is not affected by ageing, although interestingly cord blood and infant NK 
cells display very low CD16-dependent cytotoxicity compared with healthy adults (Le Garff-Tavernier 
et al., 2010; Solana et al., 1999; Solana and Mariani, 2000).  
Few studies of NKT cells in the elderly have been carried out and their numbers may increase during 
ageing (Dubey et al., 2000; Faunce et al., 2005; Ishimoto et al., 2004). This may be attributed to a 
longer life span (Berzins et al., 2006) rather than an increased proliferative capacity (DelaRosa et al., 
2002; Peralbo et al., 2007; Peralbo et al., 2006).  
4. Antigen Presenting Cells (APCs) 
Antigen presentation is a critical event in the regulation of antigen-specific immune response. 
APCs including macrophages, B cells and dendritic cells (DCs) (Uyemura et al., 2002) acquire, process 
and present pathogen-associated antigens to T cells resulting in antigen-specific immune responses 
and long lived immunity (Wordsworth and Dunn-Walters, 2011). This review focuses primarily on 
DCs. 
4.1. APC in ageing: macrophages and B cells 
Activated macrophages from aged mice have been shown to display reduced expression of MHC 
class II molecules (Herrero et al., 2001; Plowden et al., 2004; Varas et al., 2003) and were found to 
have a reduced antigen presenting ability compared to cells from younger animals (Vetvicka et al., 
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1985). A similar age-related distinction in APC activity was reported among alveolar macrophages 
(Zissel et al., 1999) which was associated with an increased risk of pulmonary infections in older 
animals. Monocyte-macrophage derived APCs in old mice were of a similar phenotype to that of cells 
from younger animals although they displayed a reduction in cytotoxicity and greater migratory 
capacity compared to young mice (Donnini et al., 2002).  
A study investigating the antigen presenting ability of B cells and monocytes in a small number of 
aged and young subjects found that in some of the older individuals appeared to have reduced APC 
capability in the B cells. This was not however, related to changes in the ability of B cells or 
monocytes to process or present antigens so there was no significant difference in the antigen 
presentation capability of these cells among young and old subjects which were comparable in the 
two age groups (Clark et al., 2012), this means that an internal process could be the cause of the 
poor antigen presentation in some of the subjects.  
4.2. APC in aging: DCs 
DCs are capable of activating naïve T cells (Uyemura et al., 2002). They capture antigens via 
various mechanisms including micropinocytosis, phagocytosis of pathogenic material, internalisation 
of heat shock proteins via receptors and by receptor-mediated endocytosis using the pattern 
recognition receptors (PRRs) C-type lectins and Fcγ receptors (Agrawal et al., 2007b). DCs act as the 
main interface between the innate and adaptive immune systems. Understanding how ageing 
impacts on their behaviour and function is therefore of central importance to understanding 
mechanisms of immunosenescence.  
4.2.1. Numbers of DC subsets with age 
The numbers of DC as a whole and of various DC subsets has been extensively investigated in 
studies making comparisons between young and aged subjects. Significant decreases in 
plasmacytoid DCS (pDCs) and CD11c+CD8+ DCs along with a significant increase in CD11c+CD8- 
myeloid DCs (mDCs) are observed in aged mice (Wong et al., 2010). Similarly, significant decreases in 
pDCs were observed in elderly human subjects (Canaday et al., 2010; Jing et al., 2009; Pérez-Cabezas 
et al., 2007; Shodell and Siegal, 2002) although the oldest sub-group of subjects tested were 50-65 
years of age, which is considered middle-aged by others (Mysliwska, 1999; Shodell and Siegal, 2002). 
Significantly lower numbers of mDCs and pDCs have been observed in the frail elderly when 
compared to both healthy young and healthy elderly subjects (Jing et al., 2009). Others however 
have found no significant differences between peripheral mDCs and pDCs between young and 
elderly subjects (Agrawal et al., 2007a) and one study observed a reduction in mDCs with age (Della 
Bella et al., 2007). Some of this conflicting data may be attributed to using the SENIEUR protocol for 
recruitment of subjects. Investigations of monocyte derived DCs (MODCs) have found that DCs 
subsets are similar in aged and young subjects (Lung et al., 2000; Steger et al., 1996). This variation 
in opinion regarding changes in numbers of DC subsets with age may reflect differences in 
experimental protocols and the number of subjects recruited in the different studies (Jing et al., 
2009). DCs are a minority cell population of blood and there is considerable individual variation in 
numbers of pDCs and mDCs with circulating blood DCs estimated to constitute between 0.1 and 
1.0% of the leucocyte population (Fearnley et al., 1999). 
4.2.2. Phenotypic alterations/maturation of DCs during ageing 
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With increasing age expression of CD25 and ICAM-1 are significantly reduced in mature MODCs 
(Ciaramella et al., 2011), though in this study comparisons were made between only 10 subjects in 
each age group. Also, in mature MODCs a significant negative correlation was found between age 
and anti-inflammatory IL-10 production along with a significant positive correlation between 
inflammatory IL-18 and IL-6 production with age. No differences were found in expression of the 
surface markers CD40, DC80, CD86 and MHC II (Wong et al., 2010) and CD86, CD80, CD54 and HLA-
DR (Agrawal et al., 2007a; Lung et al., 2000) on mDCs and pDCs, which are indicative of maturation, 
or in the response to bacterial lipopolysaccharide (LPS) between young and old subjects. These 
findings have led to the suggestion that DC functionality is unimpaired in the elderly and that DCs 
may not play a part in declining T cell function with ageing.     
4.2.3. Cytokine expression by DCs during ageing 
The production of key inflammatory immune defence cytokines such as IFN-γ is driven by DC-
derived IL-12, which is inhibited by the anti-inflammatory cytokine IL-10. Age-associated alterations 
in cytokine secretion by DCs can therefore impact on the nature and potency of T cell responses 
(Agrawal et al., 2007b). A reduction in IFN-α production by pDCs has been observed in mice (Stout-
Delgado et al., 2008) and in geriatric individuals when compared to young controls, which could not 
be explained by changes in apoptosis (Canaday et al., 2010; Sridharan et al., 2011). These findings 
indicate that reduced responses of the immune system in the elderly to influenza and other viruses 
may be due to the age-associated decreases in pDCs (Jing et al., 2009; Pérez-Cabezas et al., 2007; 
Shodell and Siegal, 2002). Impaired IFN-I and -III production by pDCs may be linked to an alteration 
in IRF-7 phosphorylation, which is impaired in DCs of aged subjects but increased in young subjects 
(Sridharan et al., 2011). Recent findings reveal that the age-associated reduction in the ability of 
monocyte derived DCs to produce IFN-I and III in response to influenza virus is linked to alterations 
in chromatin structure (Prakash et al., 2012). Surface expression of CD54 and MHC II that improve 
contact between APCs and T cells is comparable between young and elderly subjects with increases 
observed upon exposure to influenza vaccine and in the production of IL-12 and TNF-α (Saurwein-
Teissl et al., 1998). This indicates that there is no defect in DC function with age, with the reduction 
in their number perhaps contributing to the age-associated reductions in response to vaccines and 
susceptibility to infection.     
5. Ageing of the acquired immune system 
Ageing affects both the humoral and cellular arms of the acquired immune system.  
5.1 Naïve and memory T cells in aging 
During normal ageing the number of naïve T cells decreases while the number of memory T cells 
increases (Saule et al., 2006). There is an accompanying loss of functional capacity, cellular integrity, 
and diversity of both CD4+ and CD8+ T cell repertoires (Dewan et al., 2012; Haynes and Maue, 2009; 
Larbi et al., 2008; Weiskopf et al., 2009). T cells develop in the thymus, which atrophies with age 
(Flores et al., 1999; Ginaldi et al., 2001), changing the proportions of naïve and memory T cells in the 
periphery. Although memory CD4+ and CD8+ T cells are increased with ageing they are functionally 
compromised exhibiting reductions in proliferation, cytokine production, and reduced cognate 
helper function, compared with young naïve cells. Significant increases in effector/cytotoxic T cells 
(CD28-CD95+) and decreased numbers of naïve T cells (CD28+CD95-) have also been described (Zanni 
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et al., 2003). These findings are consistent with age-associated thymic involution resulting in 
reduced numbers of “virgin” naive T cells produced (Figure 2). Overall, changes in T cell effector 
function and repertoire are contributing factors in the age-associated decline of immunity to 
pathogen challenge and vaccination and increased predisposition to cancer (Hakim and Gress, 2007). 
5.1.1. Age-associated changes in CD4+ and CD8+ T cells effector functions  
Age-associated functional declines in CD4+ and CD8+ T cells impact on TCR signalling, cognate B 
cell helper function, vaccine responses, cell proliferation and cytokine production.  
CD8+ T cell cytotoxicity and proliferation decline during ageing (Haynes and Maue, 2009) whereas 
memory and cytotoxic CD8+ T cells show significantly increased expression of IFN-γ and TNF-α 
compared to those from younger individuals (Zanni et al., 2003). Thus, virus-specific memory CD8+ T 
cells have impaired proliferation and IL-2 production (Effros and Walford, 1983). Whit these changes 
in CD8+ T cell functionality, aged people are more vulnerable to viral infections (Webster, 2000). 
Non-regulatory CD8+CD45RO+CD25+ T cells that share phenotypic and functional characteristics of 
naïve CD8+ T cells are present in ~30% of the healthy elderly and can still generate protective 
humoral immune response to vaccines (Herndler-Brandstetter et al., 2005; Schwaiger et al., 2003; 
Weiskopf et al., 2009). Oligoclonal populations of CD8+ T cells appear in aged humans (Hong et al., 
2004). There is an association between the increase in the prevalence of CD8+ T cell oligoclonal 
expansion and cytomegalovirus infectious status, which establishes life-long latent infection (Akbar 
and Fletcher, 2005; Almanzar et al., 2005; Khan et al., 2002). These observations suggest a potential 
role for chronic antigenic stimulations such as cytomegalovirus infection in expanding memory CD8+ 
T cells, with aging (Clambey et al., 2007; Vasto et al., 2007).  
Naïve CD4+ T cell function in the aged decreases due to the accumulation of intrinsic and extrinsic 
defects, effectively limiting effective antibody responses (Pfister et al., 2006). The TCR signalling 
cascade shows age-related modifications as in the case of JAK/STAT pathway (Fulop et al., 2006) and 
the lipid raft polarization that affects IL-2 and IL-6 receptor signalling in T cells. Lipid rafts are 
dynamic structures that control T-cell activation and immune responses by the time-dependent 
recruitment or exclusion of signalling proteins (Alonso and Millan, 2001).  
Also, CD4+ T helper cells show different regulatory properties in old age (Haynes et al., 2005). 
Animals studies have shown a reduced ability of naïve T cells from aged animals to expand, produce 
cytokines, or differentiate, leading to the generation of poorly polarized T helper (Th) subsets (both 
Th1 and Th2) (Haynes et al., 1999; Haynes and Maue, 2009). Th1 and Th2 effector subsets however 
retain the ability to generate functional Th17 effector cells (Haynes and Maue, 2009). As a result 
aged Th17 effectors still produce high levels of IL-17-related cytokines (IL-17, IL-21, IL-22) and can 
promote antigen specific B-cell expansion and germinal centre formation (Maue et al., 2009). And, 
while naive CD4+ T cells from ageing individuals retain the ability to respond well to IL-1, IL-6, TGF-, 
and IL-23 to generate TH17 effectors, the IL-12 (for Th1) and IL-4 (for Th2) response is declined 
(Haynes and Maue, 2009). This is an important point for further studies to know how to focus the 
vaccine therapy. 
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Mechanistically the ability to produce high levels of IL-17 by aged T cells can be explained by the 
observation that CD4+T cells from elderly individuals show increased expression of the IL-
1receptor, required for the generation of IL-17-producing CD4+ T cells (Lee et al., 2010). 
5.1.2. Age-associated changes in B cells 
Compared to T cells the influence of age on B cells, is less understood although age-associated 
effects on T cells have been linked to potential alterations in the APC they interact with, including B 
cells (Magrone et al., 2008). Moderate decreases have been described in the number of naïve B cells, 
IgM memory B cell (IgG-IgA-CD27+) and switch memory B cell (IgG+IgA+), and in the proportion of IgM 
memory B cells and switch memory B cells (Blomberg and Frasca, 2011). Other studies however have 
reported an increase in memory B cells (Gibson et al., 2009). Alterations in humoral immune 
responses have a direct impact on the ability of the elderly to respond to infection (Frasca et al., 
2011). This was particularly evident in early work on a mouse model of infection with S. pneumoniae. 
These studies showed that anti-pneumococci antibody from young and aged mice differed in 
structure and protective activity against pneumococci infection (Nicoletti et al., 1991; Nicoletti et al., 
1993). It has been suggested that ageing does not result in a reduction in the function of B cells but a 
decrease in B cell responses to new antigens (Weksler, 2000). This infers alterations in the B cell 
repertoire, particularly in the heavy chain of the B cell receptor (BCR) (Buffa et al., 2011).  
The number of naïve B cells (IgD+CD27-) may also be reduced in the elderly along with increases in 
the  numbers of IgD-CD27- B cells which behave like CD27+ memory B cells and may have a role in 
immunosenescence and reduced vaccine responses (Colonna-Romano et al., 2009). This may impact 
on the availability of naïve B cells required for responses to new antigens (Buffa et al., 2011). Further 
investigations have shown that the proportion of IgM+IgD-CD27- memory B cells in the elderly is 
significantly decreased and that they produce high levels of IL-10 and TNF-α (Buffa et al., 2011). 
Analysis of the CDR3 region of the Ig heavy chain from elderly and young subjects revealed a 
decreased diversity of antibody diversity in elderly subjects, which may be a biomarker of frailty. 
Evidence of clonality between CDR3 regions from selected samples was also observed indicating the 
B cell repertoire consisted of a greater proportion of antigen experienced B cells (Gibson et al., 
2009).  
Although the elderly consistently demonstrate immune responses after immunisation, this response 
decreases in successive years (Goronzy et al., 2001b; Murasko et al., 2002). Similarly, pneumonia 
vaccination in the elderly yields a similar concentration of antibodies to that of younger subjects but 
they are less effective and opsonise bacteria less efficiently (Schenkein et al., 2008). Elderly subjects 
demonstrate significant reductions in CD27+ switch memory B cells in response to influenza 
vaccination although naïve and memory IgM B cells are comparable to those seen in young subjects 
(Frasca et al., 2010).  
6. Dietary influence on the aged immune response (improvement/restoration) 
Most of the parameters affected by immunosenescence appear to be under control genetic 
(Franceschi et al., 1999). Lifestyle factors such as diet and nutritional status, physical activity and 
stress can influence the ability to mount effective immune responses to infectious challenge 
(Lesourd, 2006). In particular, immunocompetence is directly affected by nutrition as deficiencies in 
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several vitamins and minerals, protein-energy malnutrition and excessive intakes of saturated fatty 
acids can impair immune responses (Enos et al., 2013; Lesourd, 2006; Pae et al., 2012).  
Many studies have investigated the influence of nutritional factors on the immune response in 
healthy or apparently-healthy elderly subjects, although the majority did not use the first SENIEUR 
criteria that includes some health and nutritional factors (Lesourd and Mazari, 1999). In this section 
we will summarise the most relevant nutritional studies. 
6.1. Micronutrients 
Below, we discuss the effects of different micronutrients including vitamin A, B6 and E, beta-
carotene and zinc all of which have been intensively studied (Belisle et al., 2008; Bogden et al., 1990; 
Corridan et al., 2001; De la Fuente et al., 2008; Duchateau et al., 1981; Fortes et al., 1998; Hodkinson 
et al., 2007).  
6.1.1. Vitamin E 
Vitamin E is a lipid-soluble antioxidant that enhances immune function (Gebremichael et al., 
1984; Kowdley et al., 1992) and is present in the membrane of all nucleated cells and is particularly 
abundant in the membrane of immune cells. Vitamin E includes tocopherols and tocotrienols that 
exhibit the biological activity of α-tocopherol with both synthetic and natural forms of tocopherols 
being used experimentally. Results from animal studies have established that vitamin E can enhance 
T cell functions by directly influencing membrane integrity and signal transduction or, indirectly by 
reducing production of suppressive factors such as PGE2 by macrophages (Meydani et al., 2005; Wu 
and Meydani, 2008). Many studies have reported beneficial effects of vitamin E supplementation in 
healthy elderly people (Belisle et al., 2008; De la Fuente et al., 2008; Meydani et al., 1990; Meydani 
et al., 1997; Pallast et al., 1999) with the majority finding improvements in immune function. 
However, responses to vitamin E supplementation are influenced by individual factors such as 
genetic background and previous immune status (Pae et al., 2012). One study examining the 
interaction between vitamin E treatment and cytokine production (IFN-γ, TNF-α, IL-1β, and IL-6) 
found that only subjects with prior high basal levels of cytokine production responded to 200 IU/d of 
dl--tocopherol and multivitamin and mineral supplements for 1 year with increased cytokine 
production (Belisle et al., 2008). However, other factors such as single cytokine (TNF-) gene 
polymorphisms may influence how an individual responds to vitamin E (Belisle et al., 2009). 
6.1.2. Zinc 
Zinc is an essential mineral with its deficiency leading to reduced immune cell proliferation, 
cytokine production, and specific reductions in NK cell activity and neutrophil function (Prasad, 
2008a; Prasad, 2008b). Several studies have shown beneficial effects of zinc supplementation on 
cell-mediated immunity and humoral responses in elderly people. Early studies showed that zinc 
supplementation improved DTH (delayed type hypersensitivity) responses (Cossack, 1989; Prasad, 
2003) and that consumption of 45 mg of zinc/day (as gluconate) for 6 months increased expression 
of IL-2 and IL-2 receptor (IL-2R) α mRNAs in PBMC (Prasad et al., 2006). The effects of Zn on 
lymphocyte populations are more varied. One study reported that institutionalized healthy elderly 
(≥65y) subjects had increased numbers of activated (HLA-DR+) CD4+ and cytotoxic lymphocytes after 
3 months of zinc supplementation (25mg/d as zinc sulphate) (Fortes et al., 1998), while other studies 
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reported a reduction in activated (CD25+) CD4+ T cells with no difference in Th2/Th1 (CCR4+/CCR5+) 
profiles (Kahmann et al., 2006). Zinc supplementation has also been tested for its potential 
enhancement of vaccination efficacy in the elderly although the results are inconclusive (Pae et al., 
2012). 
6.1.3. Carotenoids 
Carotenoids such as beta-carotene are stored in tissues and accumulate in the plasma and can 
be converted to vitamin A (Watson et al., 1991). They are linked to enhanced immune function as 
demonstrated by a reduction in CD45RO+ cells after supplementation and increases in sIL-2R 
production after depletion of β-carotene, lycopene and lutein. Bactericidal activity is also increased 
in supplemented individuals, while depleted subjects display elevated levels of ROS, indicative of the 
protective properties of carotenoids against oxidative stress (Farges et al., 2012). Elderly subjects 
given carotenoid supplements (30 mg β-carotene, 15 mg lycopene and 9mg lutein) had higher serum 
IgA levels, a reduction in B lymphocyte numbers, a shift to T cells expressing a mature phenotype 
and an increase in NK cells (Farges et al., 2012). While supplementation with low doses of lycopene 
(13.3 mg) or β-carotene (8.2 mg) resulted in numbers of lymphocyte subsets comparable to non-
supplemented individuals, no differences were seen in expression of adhesion molecules or MHC 
class II molecules, lymphocyte proliferation or cytokine production (Corridan et al., 2001). This lack 
of a functional response with a low dose of carotenoids may be due to the subjects having a “near-
optimal” immune status with diets already sufficient in carotenoids (Corridan et al., 2001). 
Investigations of higher doses (30-60 mg/ day) have shown improvements in immune function 
including increases in NK cell numbers and T-helper cell function (Watson et al., 1991) suggesting 
that low doses are insufficient to affect immune responses, although these higher doses may not be 
achievable in the diets of the majority of the general public.  
Fruit and vegetables containing carotenoids, flavonoids and vitamin C, with increased fruit and 
vegetable consumption from ≤2 portions per day to ≥5 portions per day have been shown to 
significantly improve the responses of 65-85 year old subjects to Pneumovax II vaccination. This 
finding was however restricted to subjects with no history of previous exposure to this vaccine 
(Gibson et al., 2012) suggesting that the influence of increasing fruit and vegetable intake may target 
naïve B cells rather than antigen experienced memory B cells. This finding may be related to the 
observation that serum levels of IgG2 increase with age, and that IgG2 is produced against 
polysaccharide antigens required for defence against bacteria such as pneumococci (Paganelli et al., 
1992).  
6.2.  Probiotics 
Probiotics are live microorganisms that may confer a health benefit to the host (consumer). The 
most characterized probiotic microorganisms are members of the genera Lactobacillus, 
Bifidobacterium and Streptococcus. Probiotics can modulate immune function in the gastrointestinal 
(GI) tract and more distant tissues via their impact on the mucosal immune system and circulating 
immune cells that traffic to and from mucosal sites. Populations of these beneficial microbes can be 
reduced in resident populations of GI-tract bacteria in elderly people in association with decreased 
intestinal antigen-specific secretory IgA responses that protect against bacteria, viruses and fungi 
(Nova et al., 2007). It is presumed therefore that elderly people would benefit from consumption of 
probiotics. 
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Several studies have examined the effects of a probiotic supplementation in healthy elderly people 
(Arunachalam et al., 2000; Gill et al., 2001b; Ouwehand et al., 2008; Schiffrin et al., 2009) although 
they are all relatively short-term interventions of less than 6 weeks. Certain strains of probiotics 
improve innate immune responses such as phagocytosis and cytotoxicity in ageing people 
(Arunachalam et al., 2000; Gill et al., 2001a; Gill et al., 2001b). Arunachalam et al (2000) showed a 
significant increase in PMN cell phagocytic and bactericidal activity to Staphylococcus aureus 
challenge after the administration of B. lactis (3x1011 CFUs/d) to healthy elderly subjects for 6 weeks. 
Gill et al. (2001a) supplemented the diet of elderly subjects with L. rhamnosus HN001 (5x1010 
CFUs/d) or B. lactis NH019 (5x109 CFUs/d) for 3 weeks and showed increases in both peripheral 
blood NK cells and their tumoricidal activity. Subsequent studies using two different doses of HN019 
(low dose 5x109 CFUs/d or typical dose 5x1010 CFUs/d) for 3 weeks revealed increases in the 
phagocytic activity of PBNC and PMN cells as well as NK cell activity for both doses (Gill et al., 
2001b). More recently, consumption of the probiotic L. casei Shirota (1.3x1010 CFU/ day) for 4 weeks 
has  shown significant increases in NK cell activity and significant decreases in expression of CD25 by 
resting T lymphocytes, along with a trend for an increase in the ratio IL-10 to IL-12 in older subjects 
(Dong et al., 2013). However, this increase in NK cell activity was greater in women, but as men had 
higher levels at baseline this could indicate that NK cell activity is modulated back to normal levels 
but is not further enhanced. Overall, the number of studies focussing on the impact of probiotics on 
immune responses in the elderly has grown in recent years. Improvements in age-related defects in 
the immune system have been demonstrated, indicating that probiotics may reduce the incidence 
and severity of infectious diseases in the elderly. Further studies are required to confirm these 
effects since the research to date has only trialled short intervention periods, and as there are 
numerous different probiotics the observed effects may be strain specific. 
6.3.  Prebiotics  
Prebiotics comprise substrates for “beneficial” gut bacteria aimed at increasing their growth. A 
novel galactooligosaccharide (B-GOS) is able to significantly increase NK cell activity after 5 weeks 
administration, reducing production of TNF-α, IL-1β and IL-6, and increasing IL-10 production by 
PBMCs, as well as increasing phagocytic activity of neutrophils and monocytes (Vulevic et al., 2008). 
These findings parallel increases in beneficial bacteria such as bifidobacteria, with the immune 
enhancing effects thought to be due to prebiotics binding to specific receptors of immune cells. 
Fructooligosaccharides (FOS) have also been shown to enhance immune function in the frail elderly 
with reductions in IL-6 and TNF-α mRNA after 12 weeks of FOS ingestion (Guigoz et al., 2002) while 
phagocytic activity was decreased after FOS ingestion for 3 weeks in older subjects (Schiffrin et al., 
2007). While, 6g/ day of a mixture of the prebiotics raftilose (70%) and raftiline (30%) did not change 
any immunological parameters tested after influenza or pneumococcal vaccination compared to the 
placebo, maltodextrin, in healthy elderly subjects (Bunout et al., 2002), which is suggested to be due 
to a potential maximum effect being achieved such that the immunological function is maintained as 
the subjects were healthy and had good nutritional status. A limited number of studies have 
investigated the impact of prebiotic intervention specifically on immune parameters in the elderly, 
with the results to date indicating potential beneficial effects.  
The use of probiotics and prebiotics together, synbiotics, has demonstrated improvements in gut 
microbiota profiles and constipation in adults (Fateh et al., 2011; Nova et al., 2011; Waitzberg et al., 
2013) though investigations in the elderly to date are limited, particularly regarding their effect on 
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immune parameters. One study found that faecal levels of PGE2 were significantly increased in 
elderly subjects (≥ 65 years) after 2 weeks consumption of lactitol and L. acidophilus NCFM, as well 
as increases in bifidobacteria numbers (Ouwehand et al., 2009). This indicates an improvement in 
mucosal function and possibly the mucosal immune system which can impact on circulatory immune 
cells. Similarly, alterations in the gut microbiota impact on immune function such that the gut is 
considered an important target for improving immune health (Hamilton-Miller, 2004) 
6.4.  Polyphenols 
Polyphenols are compounds found within many foods and beverages including red wine, fruit juices, 
fruit, vegetables, tea, coffee, cocoa and cereals (Bravo, 1998; Magrone et al., 2008). Polyphenolic 
compounds mostly consist of flavonoids, which can be further split into flavonols, flavones, 
isoflavones and flavanols (Magrone et al., 2008). In vitro investigations using MNCs from healthy 
young subjects exposed to purified polyphenols from red wine found that a dose equivalent to one 
glass of wine per day influenced the production of key cytokines including IL-12, IL-10 and IL-1β . The 
authors also showed that these polyphenols also influence B cell function and increase production of 
protective IgA and IgG. Based on the notion that polyphenols can partially restore the function of 
aged macrophages (Tasat et al., 2003) the authors speculated that moderate intake of red wine may 
be beneficial in ageing.  Animal models of ageing have shown positive results with resveratrol, a 
polyphenol found in grape skins and berries, significantly increasing T helper cells in aged rats (Yuan 
et al., 2012) and that the phytochemical, Echinacea purpurea, can increase NK cell numbers in aged 
mice to levels observed in young adult mice, as well as significantly increasing NK cell cytolytic 
activity (Currier and Miller, 2000). Limited investigations in elderly subjects have been carried out to 
date, with consumption of 40g/day cocoa (rich in flavonoids) by elderly subjects at high risk of 
cardiovascular disease (CVD) showing significantly lower expression of the cell adhesion molecules 
VLA-4, CD40 and CD36 on monocytes and lower circulating levels of the inflammatory markers P-
selectin and ICAM-1 (Monagas et al., 2009).  
6.5. Macronutrients: Fatty acids 
Cellular fatty acids have various roles including energy provision, providing structures to cell 
membranes and effecting gene expression via signalling molecules with some polyunsaturated fatty 
acids (PUFAs) acting as precursors for the synthesis of prostaglandins, leukotrienes, lipoxins and 
resolvins (Yaqoob and Calder, 2007). Different classifications of dietary fatty acids have differing 
impacts on the immune system (Yaqoob, 2004). The most studied fatty acids are the n-3 PUFA and n-
6 PUFA families, also called essentials FAs. Whereas saturated fatty acids and n-6 PUFAs have 
minimal effect on lymphocyte proliferation, cytokine production or natural killer cell activity, oleic 
acid and n-3 PUFA can inhibit lymphocyte and NK cell activity (Yaqoob, 2004). N-6 PUFAs are the 
most polyunsaturated FAs and are derived from plants and land animals. N-3 PUFAs are found 
mainly in fish and fish products and in some plants (flax seeds) with marine n-3 PUFAs, 
eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), having the most significant immune 
cell impact of all the n-3 PUFAs (Pae et al., 2012). Consumption of long chain n-3 PUFA products can 
improve cardiovascular disease, degenerative neurological disease, inflammatory and autoimmune 
diseases, and age-related macular degeneration (Pae et al., 2012). N-3 PUFA have anti-inflammatory 
properties inhibiting formation of eicosanoids (thromboxane A2) required for platelet aggregation 
and clot formation and proinflammatory cytokines (IL-1, TNF-, IL-6), chemokines (IL-8, MCP-1), 
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adhesion molecules (ICAM-1, VCAM-1, selectins), and reactive oxygen and nitrogen species (Calder, 
2010; Galli and Calder, 2009). They also suppress both innate (mainly inflammation) and adaptive (T 
cell mediated) immune responses, which can impair immunity to infectious and neoplastic disease. 
Fish oils have been shown to inhibit pro-inflammatory cytokine production by lymphocytes and 
macrophages in mice (Wallace et al., 2001). In considering the use of these PUFAs in the elderly it is 
important to consider the possible drawbacks of n-3 PUFA supplementation in individuals that have 
impaired immune responses, and that high doses of n-3 PUFAs can increase lipid peroxidation 
(Bechoua et al., 2003) and suppress IL-2 production and lymphocyte proliferation in older women 
(Meydani et al., 1991).  
There are few studies focussing on the use of n-3 PUFA in healthy aged people. Reduction in 
cytokine production and an inhibition in mitogen-induced PBMC proliferation were observed in older 
people given low levels of n-3 PUFA (1.68 g EPA and 0.72 g DHA/d) for 3 months (Meydani et al., 
1991). Another study in very old people (70-83 years of age) consuming habitual amounts of low 
doses of PUFA (30 mg EPA and 150 mg DHA/d) for 6 weeks showed a decrease in lymphocyte 
proliferation in response to different stimuli (Bechoua et al., 2003). The effects of consuming 
different doses of EPA in young and older males has shown lower neutrophil respiratory burst in 
older males with higher doses  of EPA after 12 weeks (Rees et al., 2006). Supplementation with high 
doses of EPA (1.8 g) and DHA (1.8 g) equivalent to ten portions of oily fish per week for 26 weeks 
was found to decrease levels of free fatty acids and triglycerides in association with more than 900 
unique changes in PBMC gene expression and a reduction in pro-inflammatory genes including NF-
κB target genes, pro-inflammatory cytokines and genes involved in eicosanoid synthesis (Bouwens et 
al., 2009). Lower levels of responses were seen with low doses of EPA (0.4 g) and DHA (0.4 g) 
equivalent to more realistic portions of oily fish (2 per week). Also, doses as low as 600 mg marine 
oil, consisting of 150 mg DHA and 30 mg EPA (with adequate amounts of vitamin E) given to healthy 
elderly people revealed a significant reduction in lymphocyte proliferation to mitogens and a 
significant decrease in glutathione peroxidase activity (Bechoua et al., 2003). These findings suggest 
that a lower dose of n-3 PUFAs can be beneficial and may be more suitable and achievable for older 
people, which would represent an increase in current consumption by UK elderly population who 
consume on average 85 g per week which is much less than the recommended one portion per week 
(140 g) (Bates et al., 2012). 
Prospective investigation into the effect of n-3 PUFAs on infection suggests that with increased 
intake of palmitic acid and EPA the risk of infection increases (Alperovich et al., 2007). While this 
observation was made in women, a similar study in men found an inverse association between n-3 
and n-6 and pneumonia risk (Merchant et al., 2005), which could be due to gender differences or to 
interactions of n-3 and n-6 PUFAs.  
Overall it appears that elderly individuals are more sensitive to the immunologic effects of n-3 PUFA, 
which is advantageous for the beneficial effects observed but some disadvantages such as increased 
lipid peroxidation or reductions in anti-inflammatory cytokines have also been observed with higher 
doses. As the doses used and the study designs differ between studies, more research is required to 
confirm the effects of n-3 PUFA in this age group, as well as the need to clarify the molecular 
pathways affected.  
6.6. Whole diet approaches 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
14 
 
Variations in dietary intake depend, partly, on geography as each country has its customs and 
culinary habits, which in turn influence habitual diets. Most studies investigating diet and 
immunosenescence have incorporated aspects of the Mediterranean diet (MD) with increasing 
evidence suggesting that it has a beneficial influence on several age-related diseases and improves 
immune responses (Hadziabdic et al., 2012; Martinez-Gonzalez et al., 2009; Sofi et al., 2010; Sofi et 
al., 2008). The MD refers to dietary patterns found in olive-growing regions of the Mediterranean 
characterized by a high consumption of olive oil, vegetables, fruit, nuts, cereals, and diverse 
antioxidants combined with a moderate intake of fish, poultry, and unsaturated fatty acids, a low 
intake of dairy products, red meat, processed meats, and sweets with moderate intake of alcoholic 
beverages, mostly wine, consumed with meals (Willett et al., 1995). The MD is associated with a 
significant and substantial reduction in overall mortality (Lasheras et al., 2000; Osler and Schroll, 
1997; Trichopoulou et al., 2003). 
The MD has been shown to influence cellular and circulating levels of inflammatory biomarkers 
related to atherogenesis in subjects at high risk of CVD (Estruch et al., 2013; Psaltopoulou et al., 
2004; Salas-Salvado et al., 2008). Additional experimental and clinical studies have shown that olive 
oil consumption is associated with changes in endothelia VCAM-1, ICAM-1 and E-selectin expression 
(Dell'Agli et al., 2006) and decreased plasma concentrations of sICAM-1, sVCAM-1, SE-selectin, IL-6, 
and CRP in high-risk patients (Carluccio et al., 2003; Cortes et al., 2006). Dementia, an important 
disease affecting the elderly, has been the focus of several studies. Valls-Pedret et al. (2012) have 
described improved cognitive performance in an elderly cohort at high cardiovascular risk (Valls-
Pedret et al., 2012), re-enforcing previous studies showing a slower cognitive decline (Tangney et al., 
2011), a reduction in the incidence of mild cognitive impairment (Scarmeas et al., 2009), 
neurodegenerative disorders like Parkinson (Gao et al., 2007) and Alzheimer's diseases in individuals 
adhering to the MD (Feart et al., 2009; Scarmeas et al., 2006). Although the MD has beneficial 
effects on the health of elderly people, few studies have focused on if, or how, it affects the immune 
system. The MD has been associated with the down-regulation of CD49d and CD40 expression 
among circulating monocytes and the inflammatory biomarkers sICAM-1, vCAM-1, CRP, and IL-6 
were also decreased. In other studies high levels of anti-inflammatory cytokines (IL-10) and a lower 
production of pro-inflammatory cytokines such as TNF- and IL-12 were observed after adherence 
to the MD (Azzini et al., 2011).  
The role of the diet in age-related disease needs to be investigated further. The NU-AGE project aims 
to address this need by including studies to investigate whether nutrition can act as a modulator of 
inflammaging and other age-related outcomes. This aspect of the NU-AGE project includes 1250 
older (65-79y) individuals from France, Italy, Poland, the Netherlands and the United Kingdom. The 
participants are randomised to consume the MD or remain on their normal diet. Within the UK a 
cohort of 125 elderly subjects has been recruited at The University of East Anglia (UEA) to assess at 
baseline and after 1 year of dietary intervention changes in inflammatory and immunological status, 
function and regulation. This will include expression and responsiveness of pattern recognition 
receptors, inflammatory and regulatory cytokines, expression of co-stimulatory molecules, DC 
population dynamics and innate and adaptive immune cell functionality. The aim of this work is to 
determine whether elderly subjects having conformed to the MD for one year show improvements 
in immune function. 
7. Conclusion 
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Globally, life expectancy is increasing, which means that each year the number of people over the 
age of 60 years increases. It is important therefore that older people extend their years of good 
health. Changes in nutrition and lifestyle can be effective at preventing or at least ameliorating age-
related illnesses and possibly immunosenesence. As we have summarized here, changes in the 
immune system of elderly people are well documented, indicating that most aspects of the innate 
and acquired immune systems are affected by immunosenescence. A major challenge now is to 
understand which molecular pathways of chronic inflammation (inflammaging) can be effectively 
targeted by dietary approaches. Nutritional interventions have shown some promising results in 
targeting some of the impairments of the immune system observed with ageing. Combining the 
interventions trialled thus far into a whole diet approach, such as the MD, is a realistic approach to 
take in the future. This approach is particularly suited to providing specific dietary guidelines, 
tailored to different stages of ageing.  
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Figure legends: 
Figure 1. Age-associated changes observed in innate and adaptive immune cell populations. 
Decreased cellular function in old age has been documented in neutrophils, macrophages, NK cells, 
monocyte-derived (MO) and dendritic cells (DCs). And a reduced development of T and B cells as 
well an impaired functionality of theses populations in elderly people. 
 
Figure 1. Effects of age on the production and distribution of lymphocytes. Modified from (Dorshkind 
et al., 2009) and (Nikolich-Zugich, 2008). Young and adult individuals present a normal T and B cell 
production. In contrast, elderly people have a decreased production of naïve T and B cells and an 
increase in the memory T cell poll. These changes result from decreased T‑cell production from 
involuted thymus and an increase in the homeostatic cycling that drives proliferating naïve T cells 
into memory cells, and from a decline in the bone marrow function producing fewer B cell 
precursors (Dunn-Walters and Ademokun, 2010). 
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